# India Vascular Embolization Market > India Vascular Embolization Market Research Report: By Embolization Technique (Coiling Devices, Non-coiling Devices) andBy Application (Peripheral Vascular Disease, Oncology, Neurology, Urology, Other) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 14.98% - **2024:** $ 104.41 Million - **2025:** $ 120.05 Million - **2035:** $ 484.98 Million - **Key Players:** Medtronic (US), Boston Scientific (US), Terumo Corporation (JP), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Cook Medical (US), Stryker Corporation (US), Abbott Laboratories (US), AngioDynamics (US) **Report ID:** MRFR/HC/50301-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/india-vascular-embolization-market-52059 --- ## Market Summary ## **India Vascular Embolization Market Overview** As per MRFR analysis, the India Vascular Embolization Market Size was estimated at 95.09 (USD Million) in 2023. The India Vascular Embolization Market Industry is expected to grow from 104.5(USD Million) in 2024 to 583 (USD Million) by 2035. The India Vascular Embolization Market CAGR (growth rate) is expected to be around 16.915% during the forecast period (2025 - 2035). ### **Key India Vascular Embolization Market Trends Highlighted** The India [Vascular Embolization Market](../../../reports/vascular-embolization-market-11872) is experiencing substantial growth as a result of the ageing population and the rising prevalence of vascular diseases. Key market drivers include an increase in lifestyle-related conditions, such as diabetes and obesity, which are responsible for a variety of vascular complications.  The adoption of vascular embolization procedures is also significantly influenced by government initiatives that are designed to improve healthcare infrastructure and raise public health awareness. The medical device industry in India is bolstered by favorable regulatory policies that are designed to increase the availability of advanced treatment methodologies. New opportunities are emerging as a result of technological advancements in embolization devices, such as the development of bioresorbable materials, which have garnered attention for their potential to reduce long-term complications.  Investment in research and development is essential for the development of innovative solutions that are tailored to the unique requirements of the Indian population. Furthermore, the potential for improved patient care and enhanced product offerings can result from the expansion of collaborations between domestic and international medical device manufacturers. Vascular embolization is becoming increasingly popular among both patients and healthcare providers due to the increasing emphasis on minimally invasive procedures that provide shorter recovery times and reduced discomfort. Recent trends support this view.In addition, the advent of remote monitoring and telemedicine solutions has begun to influence treatment protocols, thereby increasing the accessibility of vascular embolisation procedures in underserved regions.  This shift is also bolstered by the expanding cohort of trained healthcare personnel in interventional radiology, which introduces additional expertise to the market and provides new treatment options for patients throughout India. In general, the India Vascular Embolisation Market is poised for substantial growth in the years ahead due to the convergence of these trends. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** ## **India Vascular Embolization Market Drivers** ### **Increasing Incidence of Cancer** The India Vascular Embolization Market is experiencing significant growth driven by an increase in cancer cases. According to the Indian Council of Medical Research (ICMR), cancer cases are projected to reach approximately 1.6 million by 2025, reflecting a rise of almost 27% over five years. This increasing incidence of cancer is leading to a higher demand for interventional procedures such as vascular embolization, which are effective in treating tumors and reducing blood supply to cancerous tissues. Major hospitals and cancer treatment centers like Tata Memorial Hospital are incorporating advanced vascular embolization techniques to cater to the rising patient population, further fueling market growth. ### **Advancements in Medical Technology** The rapid progress in medical technology is playing a pivotal role in the growth of the India Vascular Embolization Market. Innovations such as microcatheters and advanced imaging techniques ensure higher precision and effectiveness in embolization procedures. The Ministry of Health and Family Welfare of India is actively promoting technological advancements in healthcare, which include funding for research and modernization of surgical instruments.As a result, leading manufacturers like Medtronic and Boston Scientific are adapting their products to meet Indian healthcare standards, significantly enhancing treatment outcomes and expanding the market. ### **Government Initiatives and Health Policies** Government initiatives aimed at improving healthcare infrastructure and accessibility in India are contributing to the growth of the India Vascular Embolization Market. The National Health Mission (NHM) has launched several programs to increase awareness and access to minimally invasive surgical options. With strategic funding allocations and public health campaigns, the government is fostering an environment that encourages the adoption of technologies like vascular embolization for treating various conditions, including liver cancer and uterine fibroids. This supportive policy environment is likely to lead to an increase in the number of procedures performed, thereby expanding the market. ### **Growing Availability of Trained Professionals** The growth in the availability of trained medical professionals in India is influencing the expansion of the India Vascular Embolization Market. As of recent data, the number of interventional radiologists has been increasing, facilitated by institutions such as the All India Institute of Medical Sciences (AIIMS) and various medical universities promoting specialized training programs in interventional radiology. This surge in trained specialists ensures that patients have more access to high-quality vascular embolization procedures, thereby increasing the market potential. The higher rate of trained professionals also enhances collaborative care, leading to improved patient outcomes and satisfaction. ## **India Vascular Embolization Market Segment Insights:** ### **Vascular Embolization Market Embolization Technique Insights** The India Vascular Embolization Market has witnessed significant advancements, particularly within the Embolization Technique segment, which encompasses various therapeutic methods used to restrict blood flow within targeted blood vessels. This segment plays a crucial role in treating a variety of medical conditions, including tumors, aneurysms, and arteriovenous malformations. Coiling Devices are known for their efficacy in preventing blood flow to aneurysms, effectively reinforcing the vessel wall and minimizing the risk of rupture. Thus, they offer essential benefits in neurovascular procedures.  On the other hand, Non-coiling Devices are gaining traction for their versatility in treating diverse vascular lesions by delivering embolic agents or mechanical devices to occlude the targeted vessels, making them an important tool in the interventional radiologist's arsenal. As the demand for minimally invasive procedures continues to rise in India, driven by the increasing incidence of vascular diseases and the rapid advancements in medical technology, the Embolization Technique segment is positioned for substantial growth. With India's healthcare system evolving and more procedures being conducted in outpatient settings, both Coiling and Non-coiling Devices are seeing an uptick in utilization, reflecting a trend toward more efficient recovery times and reduced hospitalization periods.  Moreover, heightened awareness regarding vascular health and the cost-effectiveness of embolization techniques compared to traditional surgical options is further contributing to the uptake of these devices. The Indian government and healthcare institutions are also prioritizing investments in the healthcare sector, thereby creating opportunities for innovations in this market. However, challenges such as stringent regulatory approvals and the need for extensive training for healthcare professionals to effectively use these devices pose significant hurdles.  Overall, the advancements and innovations in Embolization Techniques signify a burgeoning area within the India Vascular Embolization Market, with both Coiling Devices and Non-coiling Devices having distinct advantages that cater to the evolving needs of patients and healthcare providers. The future outlook remains optimistic as these techniques become more widely adopted, thereby enhancing patient outcomes and reinforcing the importance of interventional cardiology within the healthcare landscape of India. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** ### **Vascular Embolization Market Application Insights** The Application segment of the India Vascular Embolization Market plays a pivotal role in addressing critical health challenges faced by the population. Conditions such as Peripheral Vascular Disease, which affects a significant percentage of adults in India, underscore the importance of advanced treatment options in improving patient outcomes. Similarly, the Oncology application is crucial, as the rising incidence of cancer necessitates effective embolization procedures to manage tumors and mitigate complications. Neurology represents another vital area, with vascular interventions being essential in treating neurological disorders, thereby enhancing the quality of life for patients.Urology also contributes substantially, thanks to increased awareness of conditions like renal tumors and the effectiveness of embolization techniques in their management.  Additionally, various other applications hold importance as they encompass a range of lesser-known vascular issues, allowing for broader treatment applicability. The India Vascular Embolization Market segmentation highlights the diverse applications that cater to specific clinical needs, thereby driving growth and innovation in the industry. The interplay of factors such as rising healthcare expenditure and technological advancements in these applications is expected to bolster demand and shape the future landscape of vascular embolization in India.The market growth is significantly influenced by the increasing prevalence of vascular diseases and the need for efficient therapeutic solutions across these applications. ## **India Vascular Embolization Market Key Players and Competitive Insights:** The India Vascular Embolization Market is characterized by significant growth potential influenced by an increasing prevalence of various vascular conditions and the rising demand for innovative minimally invasive therapies. The competitive landscape is shaped by several key players, each employing distinct strategies to establish a foothold in this dynamic market.  The market's growth is prompted by advancements in medical technology, growing healthcare infrastructure, and an increasing number of surgical procedures that require embolization techniques. Companies in this sector are focusing on product development, enhancing distribution channels, and forging strategic partnerships to expand their market reach and improve service delivery. Furthermore, regulatory frameworks also play a crucial role in shaping market opportunities and challenges as companies strive to comply with safety and efficacy standards for their products. Teleflex holds a solid position within the India Vascular Embolization Market, emphasizing its commitment to improving patient outcomes through high-quality medical devices. The company benefits from a diverse portfolio of embolization products, designed to cater to various medical needs in the vascular intervention space. Teleflex's strengths lie in its innovative research and development efforts that drive the creation of advanced embolic agents and delivery systems. Moreover, Teleflex has established a robust distribution network throughout India, which enhances its accessibility and visibility within the healthcare sector.  The company's dedication to clinical support and educational initiatives further solidifies its reputation among healthcare providers, making it a preferred choice for vascular embolization solutions in the region.AngioDynamics is another important player in the India Vascular Embolization Market, offering a range of products and services tailored specifically for vascular interventions. The company focuses on providing innovative solutions such as embolic agents and delivery systems that cater to a broad spectrum of vascular conditions. AngioDynamics has made significant strides in expanding its market presence in India, leveraging strategic partnerships to enhance its distribution capabilities.  Their strengths in the sector include a strong emphasis on research and development, which enables the introduction of cutting-edge technologies that align with evolving medical needs. AngioDynamics has also engaged in mergers and acquisitions that bolster its market position and product offerings within India, ensuring that it remains competitive in this rapidly changing landscape. The company’s commitment to excellence and customer service solidifies its formidable presence in the Indian vascular embolization market. ### **Key Companies in the India Vascular Embolization Market Include:** ## **India Vascular Embolization Market Industry Developments** The India Vascular Embolization Market has recently seen significant advancements, with companies like Teleflex, AngioDynamics, and Asahi Intecc actively enhancing their product portfolios. In September 2023, Abbott Laboratories announced the launch of a new vascular embolization device aimed at improving precision in procedures, reflecting the ongoing innovation in this field. Meanwhile, B. Braun Melsungen made strides in expanding its logistics and distribution network in India to improve service delivery and reach. The market has also experienced notable partnerships as Medtronic collaborated with Stryker Corporation on joint educational initiatives, promoting better awareness and use of embolization technologies.  Additionally, in March 2023, Boston Scientific acquired a significant share in a local startup, enhancing its influence in the regional market. The Indian government’s efforts to strengthen healthcare infrastructure, as outlined in recent policy initiatives, are expected to further stimulate growth. The rising cases of cardiovascular diseases are also propelling the demand for vascular embolization procedures, thereby affecting market dynamics. Major players noted an overall increase in market valuation, spurring competitive growth and investment in Research and Development to cater to evolving patient needs. This progressive landscape, marked by mergers and acquisitions, continues to shape the future of the vascular embolization sector in India. ## **India Vascular Embolization Market Segmentation Insights** ### **Vascular Embolization Market Embolization Technique****Outlook** ### **Vascular Embolization Market Application****Outlook** ## Market Drivers ### Rising Geriatric Population The demographic shift towards an aging population in India is a significant driver for the vascular embolization market. By 2025, it is projected that approximately 10% of India's population will be aged 60 and above, leading to an increased prevalence of vascular diseases. Older adults are more susceptible to conditions such as aneurysms and varicose veins, which often require embolization procedures. This demographic trend necessitates the expansion of healthcare services tailored to the needs of the elderly, thereby boosting the demand for vascular embolization treatments. Additionally, the healthcare system is likely to adapt by enhancing its capabilities to address the specific challenges associated with treating older patients, further propelling the growth of the vascular embolization market. ### Supportive Regulatory Framework A supportive regulatory framework in India is emerging as a crucial driver for the vascular embolization market. The government is actively working to streamline the approval processes for medical devices and procedures, which encourages innovation and market entry for new technologies. Regulatory bodies are increasingly focusing on ensuring patient safety while also promoting the adoption of advanced medical solutions. As of 2025, it is expected that the time taken for regulatory approvals will decrease by around 15%, facilitating quicker access to new embolization products. This proactive approach not only enhances the competitiveness of the vascular embolization market but also ensures that patients benefit from the latest advancements in treatment options. ### Increasing Healthcare Expenditure The rising healthcare expenditure in India is a pivotal driver for the vascular embolization market. As the government and private sectors allocate more funds towards healthcare, the availability of advanced medical technologies increases. In 2025, healthcare spending in India is projected to reach approximately $370 billion, reflecting a growth rate of around 12% annually. This financial commitment facilitates the adoption of innovative embolization techniques and devices, enhancing treatment options for patients with vascular conditions. Furthermore, increased healthcare budgets allow for better training of medical professionals, ensuring that they are equipped to utilize these advanced technologies effectively. Consequently, the vascular embolization market benefits from a more robust healthcare infrastructure, which is essential for the successful implementation of these procedures. ### Advancements in Imaging Technologies The vascular embolization market is experiencing growth due to advancements in imaging technologies that enhance procedural accuracy and patient outcomes. Innovations such as 3D imaging and real-time imaging techniques are becoming increasingly integrated into embolization procedures. These technologies allow for better visualization of vascular structures, which is crucial for successful interventions. In 2025, it is anticipated that the adoption of advanced imaging modalities will increase by approximately 25%, as healthcare facilities recognize their importance in improving procedural efficacy. Enhanced imaging capabilities not only facilitate more precise embolization but also reduce the likelihood of complications, thereby fostering greater confidence among healthcare providers and patients alike. This trend is likely to drive further investment in the vascular embolization market. ### Growing Awareness of Minimally Invasive Procedures There is a notable increase in awareness regarding minimally invasive procedures among both healthcare providers and patients in India. This trend is significantly influencing the vascular embolization market, as patients increasingly prefer treatments that offer reduced recovery times and lower risks of complications. Educational campaigns and improved access to information have contributed to this shift in patient preferences. As of 2025, it is estimated that around 60% of patients are opting for minimally invasive options when available. This growing awareness not only drives demand for vascular embolization procedures but also encourages healthcare providers to invest in the necessary technologies and training. The result is a more competitive market landscape, where innovation and patient-centric approaches are prioritized. ## Future Outlook The [Vascular Embolization Market](https://www.marketresearchfuture.com/reports/vascular-embolization-market-11872) in India is projected to grow at a 14.98% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of vascular diseases, and rising healthcare expenditure. **New opportunities:** - Development of biodegradable embolic agents for enhanced patient safety - Expansion of telemedicine platforms for remote embolization consultations - Investment in AI-driven imaging technologies for improved procedural accuracy By 2035, the vascular embolization market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Technique: Coiling Devices (Largest) vs. Non-coiling Devices (Fastest-Growing) In the India vascular embolization market, coiling devices hold a significant share, capturing the majority of the market due to their established effectiveness and reliability in various embolization procedures. On the other hand, non-coiling devices are beginning to carve out their niche, appealing to a different segment of medical professionals seeking innovative solutions for complex cases. This dynamic creates a competitive landscape that is increasingly interesting for stakeholders. The growth trends in this segment are largely driven by advancements in technology and an increasing prevalence of vascular disorders that require embolization interventions. Non-coiling devices are experiencing rapid adoption, attributed to their ability to target specific conditions with enhanced precision. Furthermore, the expanding healthcare infrastructure in India is facilitating quicker access to these advanced treatment options, fostering growth in the vascular embolization market. Technique: Coiling Devices (Dominant) vs. Non-coiling Devices (Emerging) Coiling devices are predominant in the vascular embolization segment, favored for their ability to provide effective occlusion of blood vessels, which is crucial for various vascular interventions. These devices are widely used due to their long-standing history of successful outcomes and strong clinician familiarity. In contrast, non-coiling devices represent an emerging segment, characterized by their innovative features such as targeted delivery systems and bioactive materials. This emerging category is gaining traction, driven by an increasing focus on patient-specific solutions and less invasive techniques. The dynamic between these two segments illustrates the maturity of coiling devices while highlighting the potential of non-coiling devices to meet evolving clinical needs in the India vascular embolization market. ### By Application: Oncology (Largest) vs. Peripheral Vascular Disease (Fastest-Growing) The India vascular embolization market sees significant distribution among its application segments, with oncology capturing the largest share. This segment dominates due to the increasing prevalence of cancer and associated treatment advancements. In contrast, the peripheral vascular disease segment is rapidly growing, fueled by rising incidences of vascular disorders and the adoption of innovative embolization techniques. Growth trends indicate a robust trajectory for the embolization market, driven by technological advancements and increasing awareness regarding minimally invasive procedures. The oncology segment's expansion is primarily linked to rising cancer rates and improved diagnostic capabilities. Meanwhile, the peripheral vascular disease segment is experiencing significant growth, spurred by an aging population and better healthcare access across India, making it a focus area for future investments. Oncology (Dominant) vs. Peripheral Vascular Disease (Emerging) Oncology remains the dominant application segment within the India vascular embolization market, characterized by extensive research and development efforts aimed at cancer therapies. It benefits from well-established treatment protocols and a substantial patient base seeking effective solutions. In contrast, the peripheral vascular disease segment is emerging rapidly, marked by increasing awareness and a growing number of healthcare providers offering specialized services. The advancements in embolization technology and the push towards less invasive treatment options are redefining this space, appealing to a broader demographic that values quick recovery and reduced procedural risks. The interplay between these segments highlights the evolving landscape of vascular treatment options available to patients. ## Competitive Benchmarking The vascular embolization market in India is characterized by a dynamic competitive landscape, driven by technological advancements and increasing healthcare demands. Key players such as Medtronic (US), Boston Scientific (US), and Terumo Corporation (JP) are actively shaping the market through strategic initiatives. Medtronic (US) focuses on innovation in product development, particularly in minimally invasive techniques, which enhances its market positioning. Boston Scientific (US) emphasizes partnerships with local healthcare providers to expand its reach, while Terumo Corporation (JP) is investing in regional manufacturing capabilities to optimize supply chains and reduce costs. Collectively, these strategies contribute to a moderately fragmented market structure, where competition is intensifying as companies seek to differentiate themselves through advanced technologies and localized solutions.In terms of business tactics, companies are increasingly localizing manufacturing to cater to the specific needs of the Indian market. This approach not only reduces lead times but also enhances responsiveness to local demand fluctuations. The competitive structure remains moderately fragmented, with several players vying for market share. The influence of key players is significant, as their strategic decisions often set the tone for market trends and customer expectations. In October Medtronic (US) announced the launch of a new embolization device designed specifically for the Indian market, which is expected to improve patient outcomes significantly. This strategic move underscores Medtronic's commitment to innovation and its understanding of local healthcare challenges. By tailoring products to meet regional needs, the company positions itself as a leader in the market, potentially increasing its market share. In September Boston Scientific (US) entered into a strategic partnership with a leading Indian hospital chain to enhance the distribution of its embolization products. This collaboration aims to streamline access to advanced medical technologies for healthcare providers across the country. Such partnerships are crucial as they not only expand market reach but also foster trust and credibility among healthcare professionals, thereby enhancing the company's competitive edge. In August Terumo Corporation (JP) announced an investment of €10 million in expanding its manufacturing facility in India. This expansion is anticipated to bolster production capabilities and improve supply chain efficiency. By increasing local production, Terumo aims to reduce costs and enhance its ability to respond to market demands swiftly, which is vital in a rapidly evolving healthcare landscape. As of November the competitive trends in the vascular embolization market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) in product development. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in navigating complex market dynamics. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift indicates a growing emphasis on delivering superior value to healthcare providers and patients alike. ## Recent News & Developments The India Vascular Embolization Market has recently seen significant advancements, with companies like Teleflex, AngioDynamics, and Asahi Intecc actively enhancing their product portfolios. In September 2023, Abbott Laboratories announced the launch of a new vascular embolization device aimed at improving precision in procedures, reflecting the ongoing innovation in this field. Meanwhile, B. Braun Melsungen made strides in expanding its logistics and distribution network in India to improve service delivery and reach. The market has also experienced notable partnerships as Medtronic collaborated with Stryker Corporation on joint educational initiatives, promoting better awareness and use of embolization technologies.  Additionally, in March 2023, Boston Scientific acquired a significant share in a local startup, enhancing its influence in the regional market. The Indian government’s efforts to strengthen healthcare infrastructure, as outlined in recent policy initiatives, are expected to further stimulate growth. The rising cases of cardiovascular diseases are also propelling the demand for vascular embolization procedures, thereby affecting market dynamics. Major players noted an overall increase in market valuation, spurring competitive growth and investment in Research and Development to cater to evolving patient needs. This progressive landscape, marked by mergers and acquisitions, continues to shape the future of the vascular embolization sector in India. ## Report Scope | MARKET SIZE 2024 | 104.41(USD Million) | | --- | --- | | MARKET SIZE 2025 | 120.05(USD Million) | | MARKET SIZE 2035 | 484.98(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 14.98% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (US), Boston Scientific (US), Terumo Corporation (JP), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Cook Medical (US), Stryker Corporation (US), Abbott Laboratories (US), AngioDynamics (US) | | Segments Covered | Technique, Application | | Key Market Opportunities | Advancements in minimally invasive techniques enhance growth potential in the vascular embolization market. | | Key Market Dynamics | Rising demand for minimally invasive procedures drives innovation in vascular embolization technologies and regulatory adaptations. | | Countries Covered | India | ## Frequently Asked Questions **Q: What is the current valuation of the vascular embolization market in India as of 2024?** A: The vascular embolization market in India was valued at $104.41 Million in 2024. **Q: What is the projected market size for vascular embolization in India by 2035?** A: The market is projected to reach $484.98 Million by 2035. **Q: What is the expected CAGR for the vascular embolization market in India from 2025 to 2035?** A: The expected CAGR for the market during the forecast period 2025 - 2035 is 14.98%. **Q: Which companies are the key players in the India vascular embolization market?** A: Key players include Medtronic, Boston Scientific, Terumo Corporation, Johnson & Johnson, B. Braun Melsungen AG, Cook Medical, Stryker Corporation, Abbott Laboratories, and AngioDynamics. **Q: What are the main segments of the vascular embolization market in India?** A: The main segments include Technique (Coiling Devices and Non-coiling Devices) and Application (Peripheral Vascular Disease, Oncology, Neurology, Urology, and Other). **Q: How did the coiling devices segment perform in 2024?** A: In 2024, the coiling devices segment was valued at $40.0 Million. **Q: What was the valuation of non-coiling devices in the vascular embolization market in 2024?** A: The non-coiling devices segment was valued at $64.41 Million in 2024. **Q: Which application segment had the highest valuation in 2024?** A: The oncology application segment had the highest valuation at $30.0 Million in 2024. **Q: What is the projected growth for the peripheral vascular disease segment by 2035?** A: The peripheral vascular disease segment is projected to grow to $95.0 Million by 2035. **Q: How does the valuation of the neurology segment compare to other application segments in 2024?** A: The neurology segment was valued at $25.0 Million in 2024, indicating a moderate position compared to oncology and peripheral vascular disease. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-vascular-embolization-market-52059*